[{"Assets_0_Q1_USD":317217000.0,"CommonStockSharesOutstanding_0_Q1_shares":31900000.0,"EarningsPerShareBasic_1_Q1_USD":3.3,"EarningsPerShareDiluted_1_Q1_USD":3.04,"NetIncomeLoss_1_Q1_USD":104239000.0,"StockholdersEquity_0_Q1_USD":299340000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":34275000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":31632000.0,"Ticker":"RGNX","CIK":"1590877","name":"REGENXBIO INC.","OfficialName":"REGENXBIO Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1299022052.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180508"}]